I've only (cursorily) read [1] but it suggests combining different approaches for targeting immune response rather than the same approach across the populous. The risk would be assuming high levels of protection given how likely the virus is of escaping a single target through evolution. I guess that does pose a risk if people treat the current vaccines as a means to return to normal. My guess is variations on "the vaccines aren't very effective" are the biggest and most credible concerns people have though not a good reason to not receive them.